Arrowhead Pharmaceuticals, Inc 10-K for FY2026
Arrowhead Pharmaceuticals, Inc. (ARWR)
10-K
2026-11-12
For: 2026-09-30
View Original
Added on
November 12, 2026
About this 10-K
Arrowhead Pharmaceuticals, Inc filed this 10-K on November 12, 2026, covering the fiscal year ended September 30, 2026 (FY2026).
Headline figures
Fiscal year ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $450.82M
- down 45.6% from $829.45M a year earlier
- Net loss
- $724.21M
- compared with a net loss of $1.63M a year earlier
- Diluted EPS
- -$5.11
- compared with -$0.01 a year earlier